Outcomes

KE Katharine M. Esselen
AC Angel M. Cronin
KB Kristin Bixel
MB Michael A. Bookman
RB Robert A. Burger
DC David E. Cohn
MC Mihaela Cristea
JG Jennifer J. Griggs
CL Charles F. Levenback
GM Gina Mantia-Smaldone
LM Larissa A. Meyer
UM Ursula A. Matulonis
JN Joyce C. Niland
CS Charlotte Sun
DO David M. O’Malley
AW Alexi A. Wright
request Request a Protocol
ask Ask a question
Favorite

The primary outcome was the use of CA-125 testing and CT scans in the first year after remission (Cohort 1). We also examined patient factors associated with testing. Secondary outcomes included: (1) time to retreatment with chemotherapy or radiation after a documented CA-125 doubling (Cohort 2), and (2) the costs associated with surveillance testing using 2016 Medicare reimbursement rates.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A